康弘药业: 《公司章程》（2025年5月修订）

Core Points - Chengdu Kanghong Pharmaceutical Group Co., Ltd. was established on January 19, 2001, and is registered in Chengdu, China [2][3] - The company was approved by the China Securities Regulatory Commission for its initial public offering of 45.6 million shares on June 9, 2015, and was listed on the Shenzhen Stock Exchange on June 26, 2015 [2][3] - The registered capital of the company is RMB 919,869,004 [3] Company Structure - The company operates as a joint-stock limited company with a legal representative being the chairman [3] - The company’s assets are divided into equal shares, and shareholders are liable for the company's debts only to the extent of their subscribed shares [3] - The company has established a Communist Party organization to conduct activities in accordance with the Party's regulations [4] Business Objectives and Scope - The company's business objectives include the research, development, manufacturing, and sales of innovative pharmaceutical products aimed at improving patient health and social medical efficiency [4] - The registered business scope includes the research, production, and sales of pharmaceuticals and medical devices, as well as economic information consulting and import/export of goods and technology [4] Share Structure - The company issues shares in the form of stocks, with each share having a par value of RMB 1 [5] - The total number of shares issued by the company is 919,869,004, all of which are ordinary shares [5][6] - The company does not provide financial assistance to individuals or entities purchasing its shares [6] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, attend and vote at shareholder meetings, supervise company operations, and access company documents [11][12] - Shareholders are obligated to comply with laws and regulations, pay for their subscribed shares, and not abuse their rights to harm the company or other shareholders [13] Shareholder Meetings - The company holds annual and extraordinary shareholder meetings, with the annual meeting required to be held within six months after the end of the previous fiscal year [46] - Shareholder meetings can be convened by the board of directors or at the request of shareholders holding more than 10% of the shares [51][52] - Decisions at shareholder meetings require a majority or two-thirds majority vote, depending on whether the resolution is ordinary or special [78][80]